Legal Representation
Attorney
Lynn M. Jordan
USPTO Deadlines
Next Deadline
1415 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231031)
Due Date
October 31, 2029
Grace Period Ends
April 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 31, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Oct 31, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 15, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 15, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 26, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 11, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 4, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 6, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 6, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 6, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 6, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 6, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 6, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 29, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 18, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in identifying genetic markers for inherited diseases, genetic predispositions, and drug responses and for disease detection, namely, COVID-19, total cholesterol, HDL, LDL, total triglycerides, HbA1C, ALT, AST, and blood pressure
First Use Anywhere:
Jul 27, 2020
First Use in Commerce:
Jul 27, 2020
Class 042
Genomic testing for scientific research purposes; providing online databases containing scientific and genomic information in the nature of results of sequencing genes of interest in the human genome; SaaS services, namely, software enabling individuals to view results of laboratory tests and informational reports; analysis of genetic information for scientific research purposes and for the purpose of providing individuals with scientific information about genetics; providing an online open database featuring scientific information about human genetics to enable researchers to understand human genetic information; SaaS services featuring software for performing health assessments and health screening tests; SaaS services featuring software for storing, tracking, managing, analyzing, reporting, and aggregating health screening results and public and personal health data; SaaS services featuring software for reviewing and accessing genetic sequencing information and for reviewing and accessing genetic sequencing analysis, and annotated results of health data and health screening results for purposes of enabling health initiatives and public health reporting; SaaS services featuring software for population data analysis, namely, software for use in testing for and vaccinating against communicable diseases, compliance, and demographics analysis
First Use Anywhere:
Jul 27, 2020
First Use in Commerce:
Jul 27, 2020
Class 044
Providing health screening tests in the fields of infectious diseases, cardiovascular diseases, metabolic diseases, respiratory diseases, neurological diseases, renal diseases, cancer, genetic disorders, behavioral and mental health, and cancer risk assessments; medical information services, namely, reporting of authorized clinical testing results; DNA analysis and screening for diagnostic purposes and for the purpose of providing medical information; providing a website featuring medically relevant information regarding genetics and infectious diseases for educational purposes; providing health and wellness information and public health information in connection with infectious disease and genetics; genomics consulting services, namely, genetic counseling; consulting services in the fields of diagnostic medical testing
First Use Anywhere:
Jul 27, 2020
First Use in Commerce:
Jul 27, 2020
Additional Information
Design Mark
The mark consists of a stylized "O" design in which half of the "O" design is comprised of the colors yellow, purple, blue, and green. The other half of the "O" design appears in white and the center of the "O" design appears in black and is not part of the mark. The color black also represents the background and is not part of the mark.
Color Claim
The color(s) white, yellow, purple, blue, green is/are claimed as a feature of the mark.
Classification
International Classes
005
042
044